AZ 242, a novel PPARα/γ agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats
Abnormalities in fatty acid (333333333333382) metabolism underlie the development of insulin resistance and alterations in glucose metabolism, features characteristic of the metabolic syndrome and type 2 diabetes that can result in an increased risk of cardiovascular disease. We present pharmacodyna...
Main Authors: | Bengt Ljung, Krister Bamberg, Björn Dahllöf, Ann Kjellstedt, Nicholas D. Oakes, Jörgen Östling, Lennart Svensson, Germán Camejo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2002-11-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520327607 |
Similar Items
-
Rosiglitazone (BRL49653), a PPARγ-selective agonist, causes peroxisome proliferator-like liver effects in obese mice
by: Ulrika Edvardsson, et al.
Published: (1999-07-01) -
Ob jubileju
by: Jernej Weiss
Published: (2015-06-01) -
Sirtuin-2 Regulates Sepsis Inflammation in ob/ob Mice.
by: Xianfeng Wang, et al.
Published: (2016-01-01) -
The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
by: Gray Elizabeth, et al.
Published: (2012-04-01) -
Induction of obesity impairs reverse cholesterol transport in ob/ob mice.
by: MyNgan Duong, et al.
Published: (2018-01-01)